A Comparison of Three Chemotherapy Regimens for the Treatment of Patients With Newly Diagnosed Mantle Cell Lymphoma
Conditions: CCND1 Positive; Liver Lymphoma; Mantle Cell Lymphoma; t(11;14) Positive Interventions: Drug: Acalabrutinib; Drug: Bendamustine; Drug: Bendamustine Hydrochloride; Drug: Cytarabine; Biological: Rituximab Sponsors: ECOG-ACRIN Cancer Research Group; National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials